Classification and psychotropic drugs.
D014151:Anti-Anxiety Agents / Q000145:classification; D014150:Antipsychotic Agents / Q000145:classification; D001921:Brain / Q000187:drug effects; D003201:Computers; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D006993:Hypnotics and Sedatives / Q000145:classification; D008722:Methods; D008968:Molecular Conformation; D011619:Psychotropic Drugs / Q000145:classification* / Q000494:pharmacology / Q000627:therapeutic use; D011954:Receptors, Dopamine / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy; D013329:Structure-Activity Relationship; D009626:Terminology as Topic
D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents; D006993:Hypnotics and Sedatives; D011619:Psychotropic Drugs; D011954:Receptors, Dopamine; D004298:Dopamine